Literature DB >> 10331690

Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group.

D Brassat1, C Azais-Vuillemin, J Yaouanq, G Semana, J Reboul, I Cournu, C Mertens, G Edan, O Lyon-Caen, M Clanet, B Fontaine.   

Abstract

BACKGROUND: Both genetic and environmental factors play a role in the pathophysiology of MS and may influence the clinical expression of the disease.
OBJECTIVE: To determine the contribution of familial factors to the clinical expression of MS.
METHODS: The French Multiple Sclerosis Genetics Group identified 87 sibling pairs. For each patient, sex, age at onset, duration of the disease, and disease course from onset were recorded. Disability was determined by the progression index (PI), defined as the ratio of the Expanded Disability Status Scale (EDSS) score disease duration when the latter exceeded 5 years. Statistical analyses were performed either with a group of patients (clinical features, relation between human leukocyte antigen and clinical features) or with a group of sibpairs (concordance for clinical features).
RESULTS: The mean age at onset was 29.6 years, the ratio of women to men was 59:28, and the mean PI was 0.27. There was no correlation for disease course and age at onset between sibs with MS. In contrast, we observed a weak but significant correlation of the PI in MS sibpairs (r = 0.234, p = 0.03).
CONCLUSION: This study revealed a concordance in MS sibling pairs for the disease severity, supporting the hypothesis that the degree of disability might be partly influenced by familial factors (environmental or genetic).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331690     DOI: 10.1212/wnl.52.8.1632

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis.

Authors:  A E Hensiek; S J Sawcer; R Feakes; J Deans; A Mander; E Akesson; R Roxburgh; F Coraddu; S Smith; D A S Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

Review 2.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

3.  Analysing the effect of candidate genes on complex traits: an application in multiple sclerosis.

Authors:  Tineke Hooper-van Veen; Johannes Berkhof; Chris H Polman; Bernard M J Uitdehaag
Journal:  Immunogenetics       Date:  2006-04-13       Impact factor: 2.846

Review 4.  Genetic determinants of risk and progression in multiple sclerosis.

Authors:  Alessandro Didonna; Jorge R Oksenberg
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

5.  Genome-wide association study of severity in multiple sclerosis.

Authors: 
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

6.  Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Gabriele C Deluca; Katie M Morrison; Blanca M Herrera; David A Dyment; Matthew R Lincoln; Sarah-Michelle Orton; Michael J Chao; Alexandra Degenhardt; Maura Pugliatti; A Dessa Sadovnick; Stefano Sotgiu; George C Ebers
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

7.  Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA.

Authors:  Bruce A C Cree; David E Reich; Omar Khan; Philip L De Jager; Ichiro Nakashima; Toshiyuki Takahashi; Amit Bar-Or; Christine Tong; Stephen L Hauser; Jorge R Oksenberg
Journal:  Arch Neurol       Date:  2009-02

8.  Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.

Authors:  Sergio E Baranzini; Joanne Wang; Rachel A Gibson; Nicholas Galwey; Yvonne Naegelin; Frederik Barkhof; Ernst-Wilhelm Radue; Raija L P Lindberg; Bernard M G Uitdehaag; Michael R Johnson; Aspasia Angelakopoulou; Leslie Hall; Jill C Richardson; Rab K Prinjha; Achim Gass; Jeroen J G Geurts; Jolijn Kragt; Madeleine Sombekke; Hugo Vrenken; Pamela Qualley; Robin R Lincoln; Refujia Gomez; Stacy J Caillier; Michaela F George; Hourieh Mousavi; Rosa Guerrero; Darin T Okuda; Bruce A C Cree; Ari J Green; Emmanuelle Waubant; Douglas S Goodin; Daniel Pelletier; Paul M Matthews; Stephen L Hauser; Ludwig Kappos; Chris H Polman; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2008-11-14       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.